Serina Therapeutics Wins NYSE Approval Serina Therapeutics won NYSE approval on Apr 2, 2026; the exchange set a 2027 compliance deadline, giving roughly 12–21 months to meet listing standards and shape capital strategy.

Serina Therapeutics Wins NYSE Approval: Serina Therapeutics won NYSE approval on Apr 2, 2026; the exchange set a 2027 compliance deadline, giving roughly 12–21 months to meet listing standards and… 👈 Read full analysis #SerinaTherapeutics #NYSEApproval #StockMarket #FinanceNews #CapitalStrategy